GREAT WEST LIFE ASSURANCE CO /CAN/ - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 235 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
GREAT WEST LIFE ASSURANCE CO /CAN/ ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2022$107,000
+8.1%
3,336
+24.6%
0.00%
Q1 2022$99,000
+4.2%
2,677
-18.2%
0.00%
Q4 2021$95,000
+13.1%
3,2710.0%0.00%
Q3 2021$84,000
-26.3%
3,2710.0%0.00%
Q2 2021$114,000
-13.6%
3,2710.0%0.00%
Q1 2021$132,000
-25.4%
3,271
-20.0%
0.00%
Q4 2020$177,000
-21.3%
4,0870.0%0.00%
Q3 2020$225,000
-12.5%
4,0870.0%0.00%
-100.0%
Q2 2020$257,000
+23.0%
4,0870.0%0.00%0.0%
Q1 2020$209,000
-35.3%
4,0870.0%0.00%0.0%
Q4 2019$323,000
-17.4%
4,087
-45.1%
0.00%0.0%
Q2 2019$391,000
+9.5%
7,451
+10.2%
0.00%0.0%
Q1 2019$357,000
+33.2%
6,7630.0%0.00%0.0%
Q4 2018$268,000
+41.8%
6,763
+36.1%
0.00%
Q3 2018$189,000
-15.6%
4,9690.0%0.00%
-100.0%
Q2 2018$224,000
+32.5%
4,969
+42.0%
0.00%
Q1 2018$169,000
+23.4%
3,5000.0%0.00%
Q4 2017$137,000
+33.0%
3,5000.0%0.00%
Q3 2017$103,000
+7.3%
3,5000.0%0.00%
Q2 2017$96,000
-25.6%
3,5000.0%0.00%
Q1 2017$129,0003,5000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 595,473$25,790,0004.19%
Grace Capital 131,549$5,697,0003.60%
Fernwood Investment Management, LLC 201,657$8,734,0003.44%
Fairmount Funds Management LLC 215,000$9,312,0003.33%
Arctis Global LLC 293,700$12,720,0002.74%
Perceptive Advisors 5,674,711$245,771,0002.64%
ArchPoint Investors 217,510$9,420,0002.61%
Alerce Investment Management, L.P. 126,270$5,469,0002.15%
Profit Investment Management, LLC 42,196$1,826,0001.17%
Affinity Asset Advisors, LLC 50,000$2,166,0001.15%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders